Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Haemangioma
ADR ID BADD_A01897
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.02      Miscellaneous and site unspecified neoplasms benign
16.02.01      Cardiovascular neoplasms benign
16.02.01.002      Haemangioma
24      Vascular disorders
24.03      Vascular disorders NEC
24.03.06      Vascular neoplasms
24.03.06.004      Haemangioma
Description A vascular anomaly due to proliferation of BLOOD VESSELS that forms a tumor-like mass. The common types involve CAPILLARIES and VEINS. It can occur anywhere in the body but is most frequently noticed in the SKIN and SUBCUTANEOUS TISSUE. (from Stedman, 27th ed, 2000) | A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated. [MeSH]
MedDRA Code 10018814
MeSH ID D006391
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acquired haemangioma | Acquired hemangioma | Angioma | Angioma (benign) | Haemangioma | Haemangioma acquired | Haemangioma and lymphangioma, any site | Haemangioma aquired | Haemangioma NOS | Haemangioma, any site | Hemangioma | Hemangioma acquired | Hemangioma and lymphangioma, any site | Hemangioma arterial | Hemangioma cavernous | Hemangioma extensum | Hemangioma NOS | Hemangioma of other sites | Hemangioma of unspecified site | Hemangioma, any site | Nevus vascular | Haemangioma arterial | Haemangioma cavernous | Haemangioma extensum | Haemangioma of unspecified site | Naevus vascular | Cavernoma | Hemangiomas | Hemangioma, Intramuscular | Hemangiomas, Intramuscular | Intramuscular Hemangioma | Intramuscular Hemangiomas | Hemangioma, Histiocytoid | Hemangiomas, Histiocytoid | Histiocytoid Hemangioma | Histiocytoid Hemangiomas | Chorioangioma | Chorioangiomas | Chorangioma | Chorangiomas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01243Lamotrigine0.000221%
BADD_D01250Lasofoxifene--
BADD_D01281Levonorgestrel0.001040%
BADD_D01365Medroxyprogesterone--
BADD_D01401Metformin0.000005%
BADD_D01476Mirtazapine0.000080%
BADD_D01629Osimertinib0.000112%
BADD_D01633Oxaliplatin0.000112%
BADD_D01679Paroxetine0.000064%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01852Progesterone--
BADD_D01867Propranolol0.000577%
BADD_D01951Risperidone0.000242%
BADD_D01954Rivaroxaban0.000127%
BADD_D02100Sunitinib0.000112%
BADD_D02325Valdecoxib--
BADD_D02329Valproic acid0.000300%
BADD_D02344Vemurafenib0.000246%
BADD_D02373Warfarin0.000042%
BADD_D02392Zoledronic acid--
BADD_D02464Fingolimod0.006076%
The 2th Page    First    Pre   2    Total 2 Pages